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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A142size) were determined by SEM. For cell culture studies, 5mm explants
punched from bovine articular cartilage were wounded with a scalpel
and equilibrated in culture for 24h. Explants were subsequently incu-
bated with 0 or 10ng/mL of IL-1b and/or microcapsules with or without
encapsulated CNP for 96h. At the end of the culture period, samples
were analysed for NO release and GAG loss (%). Chondrocyte % viability
was assessed by incubation with calcein-AM and EtBr-1(5mM), and
quantiﬁed by ImageJ analysis. Confocal microscopy was used to detect
interaction of CNP microcapsules by incubating chondrocytes with
antibodies to natriuretic peptide receptor (Npr) 2 and 3.
Results: SEM showed uniform, 2-3 mm spherical microcapsules with
morphological characteristics similar in templates loaded with or
without CNP. The protein was localized around the inner surface of the
microcapsule shell with encapsulation efﬁciencies >82.9%. CNP release
proﬁles were broadly similar following 1-9 days of culture. The pres-
ence of CNP microcapsules did not signiﬁcantly affect cell viability
(>80%), with DNA values that remained stable throughout theculture
conditions. Microcapsules were shown to localise to wounded areas of
the explants, and confocal imaging showed clustering of microcapsules
in chondrocytes to natriuretic peptide receptor (Npr) 2 and 3. Fur-
thermore, treatment of cartilage explants with CNP microcapsules led
to concentration-dependent inhibition of NO release in response to IL-
1band restoration of matrix synthesis.
Conclusions: The present study reproducibly generated uniform
microcapsules with homogeneous morphological characteristic suit-
able for delivery and retention in the articular joint. The microcapsule
delivery system is highly effective for CNP since the peptide could be
stabilised through electrostatic interaction with the polyelectrolyte
layers sufﬁcient to allow diffusion of active CNP after localisation to
areas of damage. Furthermore, treatment of cartilage explants with
bioactive concentrations of CNP led to protective effects with sustained
release of CNP in a manner responsive to the local environment. In
summary, we demonstrate for the ﬁrst time controlled delivery of CNP
to dampen inﬂammatory effects induced by IL-1bin cartilage explants
that has the potential to promote cartilage repair in vivo.
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OBESITY DOES NOT NEGATIVELY INFLUENCE CARTILAGE REPAIR OR
CAUSE OSTEOARTHRITIS IN DBA/1 MICE
W. Wei y, Y.M. Bastiaansen-Jenniskens y, K.P. Bos y, J.A. Verhaar y,
A.-M. Zuurmond y, F. Dell'Accio z, G.J. Van Osch y. y Erasmus Univ. Med.
Ctr., Rotterdam, Netherlands; zQueen Mary Univ., London, United
Kingdom
Purpose: Traumatic cartilage damage, if left untreated, could eventually
increase the risk of developing osteoarthritis (OA). Marrow stimulation
treatments, such as microfracture, are performed to stimulate intrinsic
cartilage repair. The symptomatic improvements of microfracture are
reported to be less in obese patients and these patients are now often
excluded from treatment. Obesity is a major risk factor for OA and leads
to low grade systemic inﬂammation and metabolic changes. There is
however no convincing evidence that intrinsic cartilage repair is neg-
atively inﬂuenced by obesity. To optimize cartilage repair treatments
and to prevent OA development in obese patients, it is therefore
essential to investigate whether and how obesity inﬂuences cartilage
repair. In this study we investigated the effects of obesity on cartilage
repair and OA development in the DBA/1 mouse strain. Our hypothesis
was that obesity negatively inﬂuences intrinsic cartilage repair and
accelerates the speed of OA development after cartilage damage.
Methods: Ten-weeks-old male DBA/1 mice were fed with control diet
or obesity inducing high fat diet (HFD; 60% energy from fat). After two
weeks, a full thickness cartilage defect wasmade in the trochlear groove
of the left knee. Mice were sacriﬁced after 1 (n¼6 mice per diet), 8 (n¼9
mice per diet) and 24 (n¼5 mice per diet) weeks. Cartilage repair was
evaluated on histology using the Pineda scoring method and OA
development was evaluated using the OARSI scoring method.
Results:Mice on a HFD had higher bodyweight whenmaking the defect
(31.0±1.7gr versus 27.2±1.1gr; p<0.001) and the difference became even
larger after 24 weeks (42.0±5.8gr versus 31.7±4.6gr; p<0.001). One
week after defect creation, mice on HFD had a higher percentage of
defect ﬁlling with ﬁbroblast-like cells in the defect. After 8 weeks, mice
on a HFD had more cartilage repair as indicated by a lower Pineda score(p¼0.01). After 24 weeks, no mice had complete cartilage repair and we
were not able to detect a statistically signiﬁcant difference in Pineda
score between mice on HFD and control diet with this group size. All
mice at every time point had an OARSI score of 0, indicating no signs of
osteoarthritis.
Conclusions: Obesity did not negatively affect intrinsic cartilage repair
in DBA/1 mice. Obesity did not cause OA in DBA/1 mice, even in com-
bination with induced traumatic cartilage damage. Future research into
the inﬂammatory and metabolic changes after a high fat diet in this
strain of mice could provide more insights into the link between obesity
related changes, cartilage damage and OA development.
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CARTILAGE TISSUE ENGINEERING USING ADAMTS-4/5 DEFICIENT
MESENCHYMAL STEM CELLS
D. Wang, S. Chen, M. Esterban, M. Tortorella. Guangzhou Inst.s of
biomedicine and Hlth., CAS, Guangzhou, China
Purpose: Aggrecan is one of the two major constituents of articular
cartilage, and during diseases such as osteoarthritis (OA) it is subject to
degradation by proteolytic enzymes. The primary proteases responsible
for aggrecan cleavage are the aggrecanases, identiﬁed as members of
the disintegrin and metalloproteinase with thrombospondin motifs
(ADAMTS) family of proteases. Aggrecanase 1(ADAMTS-4) and aggre-
canase 2 (ADAMTS-5) have been reported as important therapeutic
targets in osteoarthritis. However, there is still debate which of them is
the major aggrecanase responsible for the degradation of aggrecan in
human cartilage. The aim of this study was to generate ADAMTS-4
deﬁcient and ADAMTS-5 deﬁcient chondroprogenitors derived form
human induced pluripotent stem cells (iPSCs) to enable the evaluation
of the respective roles of ADAMTS-4 and ADAMTS-5 in human cartilage
breakdown.
Methods: ADAMTS-4 deﬁcient and ADAMTS-5 deﬁcient human iPS
cells were produced by knockout of these genes in iPS cells using
Transcription Activation-Like Effector nucleases (TALENs). These iPS
cells were differentiated into chondrogenic lineage via generation of
mesenchymal stem cells (MSCs) using a multistep culture method
consisting of embryoid body (EB) formation, cell outgrowth from EBs,
monolayer culture of sprouted cells from EBs, and 3-demensional pellet
culture. Interleukin-1 (IL-1) and tumor necrosis factor (TNF) treatment
were applied after chondrogenic differentiation. The expression of type
II collagen, aggrecan, ADAMTS4, and ADAMTS-5 was measured by
quantitative real-time PCR, Western blotting, and immunoﬂuorescence
staining. The production of collagen and glycosaminoglycan (GAG) was
quantiﬁed by dye binding assays.
Results: ADAMTS-4/5 deﬁcient iPSC-derived MSCs exhibited ﬁbroblast-
like morphology similar to bone marrow MSCs and expressed surface
markers for MSCs. After 4-6 weeks of pellet culture, cells in pellet
exhibited a spherical morphology typical of chondrocytes. The
expression of type II collagen and aggrecan in pellets progressively
increased. Histological analysis revealed that ADAMTS-4/5 deﬁcient
MSC-derived pellets successfully underwent chondrogenic
differentiation.
Conclusions: These results demonstrate a model system of chon-
droprogenitors from genetically modiﬁed human iPSCs. This work also
provides potential iPSC progeny for developing cell-base approaches to
repair joint cartilage damage.
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EXTRACELLULAR MATRIX CHANGES IN RESPONSE TO SPRIFERMIN
STUDIED IN EX VIVO CULTURES OF ARTICULAR CARTILAGE
D. Reker y, A. Gigout z, C. Ladel z, M. Karsdal y, A. Bay-Jensen y. yNordic
BioSci., Herlev, Denmark; zMerck KGaA, Darmstadt, Germany
Purpose: Osteoarthritis (OA) is a degenerative disease with high
prevalence, creating an unmet medical need for drugs to protect and
regenerate cartilage. Sprifermin, a truncated form of ﬁbroblast growth
factor 18 (rhFGF18), is being investigated as a potential disease-mod-
ifying OA drug (DMOAD). Sprifermin has been shown to increase car-
tilage volume in the knees of OA patients. The few studies published
about the mode of action behind its anabolic effects, indicate that full-
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A143length (ﬂ) FGF18 induces cartilage formation by increasing chondrocyte
proliferation, resulting in increased overall extracellular matrix (ECM)
production by chondrocytes. Our hypothesis is that matrix degradation
is initially needed during this process in order to expand the lacunae
and make room in the matrix for the new chondrocytes. The aim of this
study was to characterize the ECM changes occurring in response to
direct stimulation with Sprifermin, using biomarkers of cartilage for-
mation (Pro-C2), cartilage degradation with impaired repair capacity
(C2M, AGNx2) and reversible form cartilage degradation (AGNx1).
Methods: Full depth cartilage explants (FDCex), punched from bovine
articular cartilage, were cultured for 45 days in four separate culture
plates (P1-4). Initially, the FDCex were pre-incubated either with (P1,
P2) or without (P3, P4) oncostatin M (OSM)/TNF-a (5/10 ng/mL) for 7
days, to investigate how catabolic induction inﬂuences the response to
subsequent anabolic treatment. All FDCex plates then received the same
treatments but with either single (P1, P3) or weekly (P2, P4) admin-
istration. Treatments were Sprifermin (1, 10, 50, 100 or 500 ng/mL), full-
length (ﬂ) FGF18 (100 ng/mL), IGF-I (100 ng/mL) as positive controls for
cartilage formation, or placebo as negative control, in six replicates
each. Cell viability was measured using AlamarBlue at day 45. To eval-
uate ECM changes, four biomarkers of cartilage turnover were quanti-
ﬁed in supernatants from days 14, 21, 28, 35 and 42 using well-
described ELISAs; Pro-C2 reﬂecting formation of type II collagen, C2M
and AGNx2 reﬂecting matrix metalloproteinase (MMP)-mediated deg-
radation of type II collagen and aggrecan, respectively, and AGNx1
reﬂecting aggrecanase-mediated degradation of aggrecan. Mean values
and standard error of the mean (SEM) were reported. For each time-
point, signiﬁcance levels from the placebo were found using one-way
ANOVA assuming normal distribution. These are indicated by asterisks;
*P < 0.05, **P < 0.01.
Results: Only weekly administration had an effect on the cartilage
turnover biomarkers. When comparing to placebo, the anabolic bio-
marker Pro-C2 was dose-dependently increased by Sprifermin, a
response that reached statistical signiﬁcance for the 100 and 500 ng/mL
at several time points (P < 0.05) compared to the vehicle control (ﬁg.
1A). Pre-incubation of the FDCex with OSM/TNF-a led to a decreased
and delayed response in Pro-C2 (ﬁg. 1B), which was only statistically
signiﬁcant for the 500 ng/mL dose (P < 0.05). Pro-C2 was increased by
IGF-I (pos. control) at all time points. The catabolic biomarkers C2M and
AGNx2 were not affected by any of the treatment doses. On the con-
trary, AGNx1 was slightly increased by Sprifermin however, it did not
reach statistical signiﬁcance. Cell viability was increased by all treat-
ments in a dose-dependent manner. Generally, the effect of ﬂFGF18 was
similar to Sprifermin.
Conclusions: The data presented here indicate that Sprifermin induced
increased formation of articular cartilage type II collagen ex vivo. In
addition, responsiveness of the articular cartilage to Sprifermin was
inﬂuenced by the catabolic status of the tissue prior to treatment.
Generation of MMP-mediated cleavage fragments of type II collagen
and aggrecan were unchanged by Sprifermin, but generation of the
aggrecanase-mediated cleavage fragment of aggrecan was slightly but
not statistically increased. Although additional research is needed to
conﬁrm this observation, the slight increase in AGNX1 might suggest
that matrix degradation is needed for expansion of lacunae, which may
be needed to initiate the process of cartilage formation.
Figure 1. Type II collagen formation, Pro-C2. In two parallel experiments,
bovine FDCex were pre-incubated for 7 days with (B) or without (A) OSM/
TNF-alpha (5/10 ng/mL), and then cultured further 35 days with weekly
adddition of indicated treatments. Pro-C2 (Nordic Bioscience) released to
the supernatant was measured to reﬂect type II collagen formation. Val-
ues are means ± SEM of six replicate FDCex. One-way ANOVA was used to
compare each point with its respective placebo-treated group. Sig-
niﬁcance levels are indicated by asterisks; *P < 0.05, **P < 0.01.207
EFFECT OF SELF ASSEMBLED PEPTIDE-SUBSTANCE P ON
PROGRESSION OF OSTEOARTHRITIS
S. KIM y, Y. Jung z, J. Kim z, Y. Cho y, S. Kim y. y Samsung Med. Ctr., Seoul,
Republic of Korea; zKorea Institue of Sci. Technology, Seoul, Republic of
Korea
Purpose: Substance P (SP) is known as a neuropeptide to recruit
intrinsic stem cells and to ameliorate arthritis via suppression of the
catabolic pathway. Self assembled peptide (SAP) hydrogel has a function
of releasing a neuropeptide slowly and incorporating speciﬁc motifs
based on desired function. The purpose of this study is to ﬁnd that SAP-
SP complex would inhibit the catabolic pathway caused by the osteo-
arthritis and enhance the cartilage regeneration by the recruitment of
intrinsic mesenchymal stem cells.
Methods: A total of 70 female Sprague Dawley rats underwent surgical
procedure (anterior cruciate ligament resection and medial meniscec-
tomy) for the osteoarthritis model. Mesenchymal stem cells were
acquired from the bone marrow of additional 5 Sprague Dawley rats.
KLD-12 was used as the SAP hydrogels and they were conjugated with
diverse amount of SP (17.5 mg, 35 mg, 70 mg). Ten rats were used for the
evaluation of biotinylated SAP-SP disappearance. Fifty rats were divided
into 5 groups: SAP (n¼10), SAP-SP17.5 (n¼10), SAP-SP35 (n¼10), SAP-
SP70 (n¼10), SAP-SP-MSC (n¼10), and control (n¼10) groups. Total 2ml
of SAP, SAP conjugated with diverse amount of SP, and normal saline
were injected into the left knee joint in each group 3weeks postsurgery.
Histologic examination, immunoﬂuorescent staining and qRT-PCR
for caspase-8 and TIMP-1, TUNEL assay for the chondrocyte apop-
tosis, and micro-computed tomography were conducted 6 weeks
after injections. Cell markers for the recruitment of intrinsic mes-
enchymal stem cells (CD90 and CD105) were evaluated by the
immunoﬂuorescent analysis. Behavioral studies were done before, 3
weeks after, and 6 weeks after treatment.
Results: Biotinylated SAP-SP stayed within the knee joint till 6 weeks
after the injection.Modiﬁed mankin scoreswere signiﬁcantly lower in
SAP-SP17.5 and SAP-SP35 groups than control group (P¼0.011 and
0.013). Immunoﬂuorescent staining and gene expression of caspase-8
and TIMP was signiﬁcantly lower in SAP-SP17.5, SAP-SP35, and SAP-
SP70 groups than control group. Expression of CD90 and CD105 was
higher in SAP-SP17.5, SAP-SP35, and SAP70 groups than other groups.
TUNEL assay showed decrease of apoptosis in SAP-SP17.5 and SAP-SP35
groups. However, neither bone mineral density nor behavioral results
showed any signiﬁcant difference between groups.
Conclusions: Injection of SAP-SP hydrogels improved histologic
changes of osteoarthritis and this might be due to the recruitment of
intrinsic mesenchymal stem cells, inhibition of catabolic pathway
and anti-apoptotic effect.
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AXIAL KNEE ALIGNMENT INFLUENCES THE REPAIR OF FOCAL
ARTICULAR CARTILAGE DEFECTS e A TRANSLATIONAL STUDY IN
SHEEP
L. Goebel y, P. Orth y, A. Müller z, U. Wolfram x, D. Zurakowski 4,
A. Ignatius ¶, A. Bücker z, D. Pape#, M. Cucchiarini y, H. Madry y. yCtr. of
Experimental Orthopaedics, Homburg, Germany; zDept. of Diagnostic and
Interventional Radiology, Homburg, Germany; x Inst. for Surgical
Technology & Biomechanics, Bern, Switzerland; kDept.s of Anesthesia
and Surgery, Boston, MA, USA; ¶ Inst. of Orthopaedic Res. and
Biomechanics, Ulm, Germany; #Dept. of Orthopaedic Surgery,
Luxembourg, Luxembourg
Purpose: Marrow stimulating techniques are excellent options to treat
small symptomatic cartilage defects. However, the effect of axial
alignment on the repair of focal (non-OA) articular cartilage defects
remains unknown. Here, we tested the hypothesis, that unloading of a
full-thickness cartilage defect in the weight-bearing area of the sheep
medial femoral condyle by valgisation high tibial osteotomy (HTO)
results in improved cartilage repair in a sheep stiﬂe joint compared to
increased loading as induced by varus osteotomy. We further
hypothesized that a standard valgus correction is superior to
overcorrection.
Methods: Adult merino sheep (n¼ 19; 66.6 ± 5.0 kg) received bilateral
standardized (rectangular, 4 x 8 mm) full-thickness cartilage defects
treated by subchondral drilling. Additionally, all right hind legs
received a medial biplanar osteotomy of the proximal tibia (3 groups):
